MedPath

Tazmuz 1

Brand Name: Tazmuz 1

Generic Name: Tacrolimus

Active
Registration Number

DRP-15538

Dosage Form

Capsule

Issuance Date

July 31, 2024

Expiry Date

July 31, 2029

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength1 mg
PackagingAlu/Alu Blister Pack x 10's (Box of 10's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Calcineurin Inhibitor
A
Application
Initial
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

TacrolimusActive
Monograph: Tacrolimus

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform